Welcome to the 4th Cannabinoid Derived Pharmaceuticals Summit
Returning for its 4th year, the Cannabinoid Derived Pharmaceuticals Summit is comprehensively addressing (more than ever before) the industry’s key challenges all the way from bench to bedside, ensuring cannabinoid therapeutics fulfil their true potential.
With dozens of clinical opportunities having been identified as potential targets for cannabinoid therapy, and with current therapeutics failing to serve a vast array of unmet clinical needs, the burgeoning field of cannabinoid pharmaceuticals is gathering pace.
This meeting will be the center point for exploring a broad variety of therapeutic applications for cannabinoids and overcoming the critical barriers that are obstructing companies from reaching their goals.
Alongside your peers, you have the opportunity to hear from and interact with 30+ thought leaders in our expert speaker faculty, have access to 26+ hours of content exploring the latest advances in the cannabinoid and ECS field, form meaningful and long-lasting connections in the multiple and varied virtual networking sessions built into the event.